Dexcom Inc
dexcom.comDexcom Inc (NASDAQ: DXCM) is a medical device company that designs, develops, and manufactures continuous glucose monitoring (CGM) systems. Revenue is generated through the sale of CGM hardware sensors and transmitters, with sensors consumed on a recurring basis by patients, creating a high-frequency consumable revenue stream. Dexcom is listed on the Nasdaq Global Select Market. The filing confirms the company is a well-known seasoned issuer as of its 10-K filed February 12, 2026, covering fiscal year ended in 2025. The aggregate market value of common stock held by non-affiliates was approximately $87.29 per share as of June 30, 2025, the last business day of the second fiscal quarter.
Products & Services
Continuous glucose monitoring (CGM) systems, including wearable sensors, transmitters, and receivers, sold under the Dexcom brand.
Revenue Model
Transactional and consumable-driven. Dexcom sells CGM sensors, transmitters, and receivers directly and through distribution channels. Sensors are worn-and-replaced devices, generating repeat purchases from existing patients.
Customers & Markets
Diabetes patients (type 1 and type 2) and healthcare providers. Products are distributed through pharmacy, durable medical equipment, and direct channels.
Geographic Exposure
Filing does not provide a geographic revenue breakdown in the excerpts provided.
Loading...
